XORTX Therapeutics Inc. (XRTX)
NASDAQ: XRTX · Real-Time Price · USD
0.631
-0.000 (-0.03%)
At close: Dec 5, 2025, 4:00 PM EST
0.620
-0.011 (-1.73%)
After-hours: Dec 5, 2025, 5:47 PM EST
XORTX Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 4 | 4 | 4 | 12 | 26 | 9 | |
| Market Cap Growth | -13.14% | -6.84% | -63.14% | -53.60% | 177.78% | 19.02% | |
| Enterprise Value | 3 | 2 | -1 | 3 | 22 | 9 | |
| Last Close Price | 0.63 | 1.13 | 2.31 | 7.27 | 18.45 | 12.26 | |
| PB Ratio | 2.13 | 1.23 | 0.95 | 1.70 | 1.94 | 9.37 | |
| P/TBV Ratio | 2.37 | 1.30 | 0.98 | 1.75 | 1.97 | 11.52 | |
| Debt / Equity Ratio | 0.03 | 0.01 | 0.00 | 0.01 | - | - | |
| Quick Ratio | 1.45 | 3.29 | 4.25 | 6.96 | 26.97 | 0.18 | |
| Current Ratio | 1.62 | 3.53 | 4.93 | 7.21 | 28.78 | 1.99 | |
| Return on Equity (ROE) | -94.63% | -83.06% | -37.08% | -76.43% | -22.25% | -245.97% | |
| Return on Assets (ROA) | -45.32% | -34.21% | -34.72% | -38.82% | -15.04% | -40.80% | |
| Return on Capital (ROIC) | -71.41% | -40.74% | -52.83% | -56.97% | -20.34% | -125.84% | |
| Return on Capital Employed (ROCE) | -122.40% | -78.40% | -106.80% | -85.10% | -13.70% | -87.80% | |
| Earnings Yield | -46.15% | -81.03% | -49.17% | -64.82% | -6.15% | -10.91% | |
| FCF Yield | -70.13% | -89.96% | -150.08% | -68.74% | -18.71% | -6.19% | |
| Buyback Yield / Dilution | -53.07% | -45.25% | -33.91% | -35.25% | -47.77% | -24.34% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.